Market Exclusive

Analyst Activity – Royal Bank Of Canada Reiterates Buy on Abbott Laboratories (NYSE:ABT)

Analyst Ratings For Abbott Laboratories (NYSE:ABT)

Today, Royal Bank Of Canada reiterated its Buy rating on Abbott Laboratories (NYSE:ABT) with a price target of $55.00.

There are 4 hold ratings, 8 buy ratings on the stock.

The current consensus rating on Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.67) with a consensus target price of $54.75 per share, a potential 1.99% upside.

Some recent analyst ratings include

Dividend information for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) pays an annual dividend of Community Ranking: with a yield of 1.97% and an average dividend growth of 22.90% based on a 3 Year Average.

Dividend History for Abbott Laboratories (NYSE:ABT)

Recent Insider Trading Activity For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) has insider ownership of 0.76% and institutional ownership of 71.50%.

Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
Shares of Abbott Laboratories closed the previous trading session at with shares trading hands.

Exit mobile version